source
- 'Still a bull': Novo's CEO on honoring heritage and planning for the future amid corporate rebrandNovo CEO Mike Doustdar—tapped to breathe new life into the Danish drugmaker last year after losing GLP-1 marketing ground to chief rival Eli Lilly—isn’t one to make changes for the sake of change.
- Experts assess EU medical device and diagnostic regulations at RAPS Convergence 2026A panel of experts representing the European Commission, industry groups and notified bodies gathered in Charlotte, North Carolina during RAPS Convergence 2026. The group reviewed the current stat…